Search Results
Jun 07, 2026, 20:10 ET Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39
View original content to download multimedia:
More news about: Ascletis Pharma Inc.
Jun 07, 2026, 20:08 ET OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
View original content:
More news about: Oricell Therapeutics Holdings Limited
Jun 07, 2026, 20:00 ET BLACKYAK舉辦「2026喜馬拉雅氣候憲章：南池峰會」，推動全球氣候行動
View original content to download multimedia:
More news about: BLACKYAK
Jun 07, 2026, 20:00 ET UPST Deadline: UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit
View original content to download multimedia:
More news about: THE ROSEN LAW FIRM, P. A.
Jun 07, 2026, 20:00 ET Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
View original content to download multimedia:
More news about: Antengene Corporation Limited
Jun 07, 2026, 19:05 ET El décimo "67 Brand Customer Day" de Dongfeng Liuzhou Motor avanza en nuevas vías para el crecimiento global
View original content:
More news about: Dongfeng Liuzhou Motor Co., Ltd.
Jun 07, 2026, 18:54 ET Bitmine Immersion Technologies 宣佈增額 A 系列永續優先股招股定價
View original content to download multimedia:
More news about: Bitmine Immersion Technologies, Inc.
Jun 07, 2026, 18:52 ET Sportradar Group AG (SRAD) Investors: July 17, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP
View original content to download multimedia:
More news about: Kessler Topaz Meltzer & Check, LLP
Jun 07, 2026, 18:30 ET VolitionRx Announces Pricing of $4.6 Million Public Offering
View original content:
More news about: VolitionRx Limited
Jun 07, 2026, 18:13 ET FSK Investors Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit
View original content to download multimedia:
More news about: THE ROSEN LAW FIRM, P. A.
Jun 07, 2026, 17:30 ET Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
View original content to download multimedia:
More news about: American Diabetes Association
Jun 07, 2026, 17:30 ET Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
View original content to download multimedia:
More news about: NOVO NORDISK INC.
Jun 07, 2026, 17:13 ET Quantinuum 宣布其增額首次公開招股已完成交割
View original content:https://www.prnewswire.com/apac/zh/news-releases/quantinuum--302793455.htmlSOURCE
More news about: Quantinuum
Jun 07, 2026, 16:45 ET Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
View original content to download multimedia:
More news about: American Diabetes Association
Jun 07, 2026, 16:45 ET AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
View original content to download multimedia:
More news about: Amgen
Jun 07, 2026, 16:42 ET Quantinuum anuncia el cierre de su oferta pública inicial ampliada
View original content:
More news about: Quantinuum
Jun 07, 2026, 16:39 ET Quantinuum anuncia o fechamento de oferta pública inicial ampliada
View original content:
More news about: Quantinuum
Jun 07, 2026, 16:04 ET CERAVE VÍTA NA PRVÝCH GLOBÁLNYCH CENÁCH CERAWARDS VIAC AKO 100 OCENENÝCH TVORCOV OBSAHU Z 22 KRAJÍN
View original content to download multimedia:
More news about: CeraVe
Jun 07, 2026, 14:30 ET 頭對頭：埃諾格魯肽體重降幅顯著優於司美格魯肽35%
View original content:https://www.prnewswire.com/apac/zh/news-releases/35-302793401.htmlSOURCE
More news about: 杭州先為達生物科技股份有限公司
Jun 07, 2026, 14:30 ET Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
View original content to download multimedia:
More news about: American Diabetes Association
Jun 07, 2026, 14:30 ET Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
View original content:
More news about: Sciwind Biosciences Co., Ltd.
Jun 07, 2026, 13:24 ET Rosen Law Firm Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation - DNOW
View original content to download multimedia:
More news about: THE ROSEN LAW FIRM, P. A.
Jun 07, 2026, 12:00 ET Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm
View original content to download multimedia:
More news about: Bronstein, Gewirtz & Grossman, LLC
Jun 07, 2026, 12:00 ET Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
View original content to download multimedia:
More news about: Bronstein, Gewirtz & Grossman, LLC
Jun 07, 2026, 11:00 ET Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
View original content to download multimedia:
More news about: Eli Lilly and Company